Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Arginine:glycine aminotransferase (AGAT) (GATM) deficiency is an autosomal recessive inborn error of creative synthesis. OBJECTIVE: We performed an international survey among physicians known to treat patients with AGAT deficiency, to assess clinical characteristics and long-term outcomes of this ultra-rare condition. RESULTS: 16 patients from 8 families of 8 different ethnic backgrounds were included. 1 patient was asymptomatic when diagnosed at age 3 weeks. 15 patients diagnosed between 16 months and 25 years of life had intellectual disability/developmental delay (IDD). 8 patients also had myopathy/proximal muscle weakness. Common biochemical denominators were low/undetectable guanidinoacetate (GAA) concentrations in urine and plasma, and low/undetectable cerebral creatine levels. 3 families had protein truncation/null mutations. The rest had missense and splice mutations. Treatment with creatine monohydrate (100-800 mg/kg/day) resulted in almost complete restoration of brain creatine levels and significant improvement of myopathy. The 2 patients treated since age 4 and 16 months had normal cognitive and behavioral development at age 10 and 11 years. Late treated patients had limited improvement of cognitive functions. CONCLUSION: AGAT deficiency is a treatable intellectual disability. Early diagnosis may prevent IDD and myopathy. Patients with unexplained IDD with and without myopathy should be assessed for AGAT deficiency by determination of urine/plasma GAA and cerebral creatine levels (via brain MRS), and by GATM gene sequencing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112 · cited 1×
“A proportion of the cerebral creatine content is derived from intracerebral creatine synthesis [21] facilitated by AGAT and GAMT expression in various brain cell types [22].”
BackgroundBattini, R., Alessandrì, M. G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M. C., & Cioni, G. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.043 · Cited by 101 · cited 3×
“Early diagnosis and treatment seems to be particularly efficient in improving outcomes [4,10].”
BackgroundSelf-citationNdika, J. D. T., Johnston, K., Barkovich, J. A., Wirt, M. D., O'Neill, P., Betsalel, O. T., Jakobs, C., & Salomons, G. S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.01.017 · Cited by 40
Self-citation
Cited by
Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review
Bonilla, D. A., Kreider, R. B., Stout, J. R., Forero, D. A., Kerksick, C. M., Roberts, M. D., & Rawson, E. S. (2021) · Nutrients · doi:10.3390/nu13041238 · Cited by 223
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
Hanna-El-Daher, L., & Braissant, O. (2016) · Amino Acids · doi:10.1007/s00726-016-2189-0 · Cited by 65
Ostojic, S. M., Ostojic, J., Drid, P., & Vranes, M. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0178 · Cited by 51
Metadata
- Authors
- Stockler-Ipsiroglu, S., Apatean, D., Battini, R., DeBrosse, S., Dessoffy, K., Edvardson, S., Eichler, F., Johnston, K., Koeller, D. M., Nouioua, S., Tazir, M., Verma, A., Dowling, M. D., Wierenga, K. J., Wierenga, A. M., Zhang, V., & Wong, L.-J. C.
- Venue
- Molecular Genetics and Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 116
- Issue
- 4
- Pages
- 252-259
- ISSN
- 1096-7192 (ISSN-L)
- OpenAlex
- W1957050290
- Cited by
- 69
- References
- 3
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. https://app.cochat.ai/papers/10.1016/j.ymgme.2015.10.003
- The paper
- Stockler-Ipsiroglu, S., Apatean, D., Battini, R., DeBrosse, S., Dessoffy, K., Edvardson, S., Eichler, F., Johnston, K., Koeller, D. M., Nouioua, S., Tazir, M., Verma, A., Dowling, M. D., Wierenga, K. J., Wierenga, A. M., Zhang, V., & Wong, L.-J. C. (2015). Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. Molecular Genetics and Metabolism. https://doi.org/10.1016/j.ymgme.2015.10.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.